Skip to content

13F-HR filed by Antara Capital LP

Antara Capital LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 33 holding rows worth $481,991,000.

Accession
0001750183-21-000002
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 33 entries on the cover page, a total value of $481,991,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $481,991,000 with VALUE read as thousands by filing date, 13F file number 028-19352. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CAESARS ENTERTAINMENT INC NE12769G950PUT1,950,000$144,827,000thousands by filing dateput
TIFFANY CO886547958COM675,900$88,847,000thousands by filing dateput
WORKHORSE GROUP INC98138J956COM NEW2,237,500$44,258,000thousands by filing dateput
QUANTUMSCAPE CORP74767V909CALL520,300$43,939,000thousands by filing datecall
USA Technologies Inc903285500COM1,642,695$17,215,000thousands by filing date
UNIQURE NVN90064951SHS452,500$16,349,000thousands by filing datecall
LUMINAR TECHNOLOGIES INC550424955OPTION465,000$15,810,000thousands by filing dateput
TG THERAPEUTICS INC88322Q908COM294,600$15,325,000thousands by filing datecall
DISH NETWORK CORP-A25470M959COM400,000$12,936,000thousands by filing dateput
AURINIA PHARMACEUTICALS INC05156V902COM643,500$8,900,000thousands by filing datecall
AURINIA PHARMACEUTICALS INC05156V952COM609,500$8,429,000thousands by filing dateput
REVLON INC761525959PUT650,000$7,722,000thousands by filing dateput
SPDR SERIES TRUST78464A905CALL200,000$6,688,000thousands by filing datecall
BLINK CHARGING CO09354A900COM150,000$6,413,000thousands by filing datecall
COLONY CAP INC NEW19626G908Option1,000,000$4,810,000thousands by filing datecall
VELODYNE LIDAR INC92259F951PUT200,000$4,564,000thousands by filing dateput
TG THERAPEUTICS INC88322Q958COM78,600$4,089,000thousands by filing dateput
INVENTIVA SA46124U107ADS259,857$3,768,000thousands by filing date
BARNES & NOBLE ED INC06777U101COM807,755$3,756,000thousands by filing date
INNOVIVA INC45781M101COM295,000$3,655,000thousands by filing date
OMEROS CORP682143AG7NOTE 5.250% 2/13,000,000$3,197,000thousands by filing dateprincipal
AMERICAN AIRLINES GROUP INC02376R902CALL200,000$3,154,000thousands by filing datecall
COLLECTIVE GROWTH CORP19424L101COM CL A198,448$2,836,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM83,926$2,073,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P958COM75,000$1,853,000thousands by filing dateput
PRECIGEN INC74017N905CALL150,000$1,530,000thousands by filing datecall
REDBALL ACQUISITION CORPG7417R105COM CL A108,604$1,183,000thousands by filing date
REVLON INC. - CL A CMN STOCK761525909Cmn91,600$1,088,000thousands by filing datecall
ENLINK MIDSTREAM LLC29336T950COM UNIT REP LTD250,000$928,000thousands by filing dateput
THERAVANCE INC88338TAB0CORPORATE OBLIG3,100,000$857,000thousands by filing dateprincipal
INTERCEPT PHARMACEUTICALS IN45845PAA6NOTE 3.250% 7/07,609,000$435,000thousands by filing dateprincipal
CLOVIS ONCOLOGY INC189464AC4NOTE 1.250% 5/037,028,000$353,000thousands by filing dateprincipal
CLOVIS ONCOLOGY INC189464950PUT42,500$204,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001750183-21-000002this filing2021-02-16acceptance time not in the bulk data set